Acute changes in the retina and central retinal artery with methamphetamine

scientific article published on 07 February 2020

Acute changes in the retina and central retinal artery with methamphetamine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EXER.2020.107964
P932PMC publication ID7113125
P698PubMed publication ID32044305

P2093author name stringNorman R Harris
Wendy Leskova
Minsup Lee
Randa S Eshaq
P2860cites workRetinal degeneration mutants in the mouseQ28202375
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrierQ28235057
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamineQ28235275
Mechanisms of neurotransmitter release by amphetamines: a reviewQ28256434
The blood-brain barrier: an overview: structure, regulation, and clinical implicationsQ29616839
PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristicsQ31825950
Matrix metalloproteinases in human diabetic and nondiabetic vitreousQ32058683
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migrationQ33188043
Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-RasQ34022639
Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stressQ34504916
Ocular manifestations of crystal methamphetamine use.Q34977154
Protease Activity and the Role of the Endothelial Glycocalyx in InflammationQ35503145
Mechanisms of methamphetamine-induced dopaminergic neurotoxicityQ35594901
The TNF-α/NF-κB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunctionQ35925469
Gap junction contributions to the goldfish electroretinogram at the photopic illumination levelQ36089815
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substratesQ36305029
MT1-MMP: a key regulator of cell migration in tissueQ36627872
Relationship between methamphetamine exposure and matrix metalloproteinase 9 expressionQ37052569
Cerebrovascular complications of methamphetamine abuseQ37365316
MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injuryQ37716860
Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potentialQ37750085
PECAM-1: regulator of endothelial junctional integrityQ38179296
Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.Q38302183
Breakdown of Blood-Brain and Blood-Spinal Cord Barriers During Acute Methamphetamine Intoxication: Role of Brain TemperatureQ39361706
MMP-14 mediated MMP-9 expression is involved in TGF-beta1-induced keratinocyte migrationQ40007919
Significance of outer blood-retina barrier breakdown in diabetes and ischemiaQ41924777
Toxic effect of methamphetamine on the retina of CD1 miceQ42184970
Cardiac remodeling after long term norepinephrine treatment in rats.Q43782715
Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cellsQ43825285
Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry.Q43847144
Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidationQ44135794
Methamphetamine exacerbates the toxic effect of kainic acid in the adult rat retina.Q45068514
Ischemic stroke associated with methamphetamine inhalationQ46549559
Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamusQ46684384
Central retinal artery occlusion associated with intranasal methamphetamine use.Q46975802
Clinical Characteristics of Fatal Methamphetamine-related Stroke: A National StudyQ47639400
Production and Activation of Matrix Metalloproteinase-2 in Proliferative Diabetic RetinopathyQ47952325
Dopamine and serotonin in cat retina: electroretinography and histologyQ48160487
Methamphetamine Causes Photoreceptor Cell Damage Through Promoting Polarization of Macrophages and Inducing Inflammatory ResponseQ48185553
Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications.Q52582675
Enhanced phosphorylation of MAPKs by NE promotes TNF-α production by macrophage through α adrenergic receptor.Q54589154
Long-Term Systemic Treatment With Methamphetamine Causes Retinal Damage in CD1 MiceQ58103602
Loss of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) in the Diabetic Retina: Role of Matrix MetalloproteinasesQ64270971
Bilateral methamphetamine-induced ischemic retinopathy.Q64890577
Amaurosis fugax and retinal vasculitis associated with methamphetamine inhalation.Q64979623
Sudden Retinal Manifestations of Intranasal Cocaine and Methamphetamine AbuseQ68231429
Recurrent corneal ulcerations associated with smokeable methamphetamine abuseQ71025501
Keratitis in methamphetamine abusersQ71666371
Acute unilateral visual loss due to a single intranasal methamphetamine abuseQ77832306
Effects of crocetin on the matrix metalloproteinases in cardiac hypertrophy induced by norepinephrine in ratsQ79974542
Crystalline retinopathy from nasal ingestion of methamphetamineQ80237860
Catecholamines can induce pulmonary remodeling in ratsQ85502682
P4510describes a project that usesImageJQ1659584
P304page(s)107964
P577publication date2020-02-07
P1433published inExperimental Eye ResearchQ15754753
P1476titleAcute changes in the retina and central retinal artery with methamphetamine
P478volume193